VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
OGI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
OGIOrganigram Global Inc.
$0.88$123M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
OGI logo

Organigram Global Inc.

OGI
NASDAQ · Cannabis
$0.88
At close - Nov 6, 4:00 PM EST - USD
Market Cap$123M
P/E2.0x
52W High$2.24
Volume1.12M
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q3

Volatile Earnings Spike Lacks Cash Flow Support

OGI's 2026Q3 net income of $105.5M appears driven by non-operating or one-time items, since operating income was only $5.3M on a 5.0% margin, and operating cash flow was negative at -$4.3M, suggesting weak earnings quality.

GrowthMixed
ProfitabilityWeak
ValuationAttractive
TechnicalsWeak
Explore valuation models
MARKET ACTION

OGI price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

6/12 Beats

EPS beat 6 of last 12 quarters

02

Valuation risk

-91% Peers

P/E is 91% below peer median

03

Market leadership

RS 25 · Lag

Laggard (Underperforming 75% of market)

04

Weak Trend

Below 200DMA

Price < 200DMA

Next CatalystConfirmed earnings · Dec 15

Market performance

Price History →

Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
OGI-49.33%
S&P 500 (^GSPC)+7.63%
1-Year Return
OGI-40.77%
S&P 500 (^GSPC)+9.69%
3-Year Return
OGI-36.48%
S&P 500 (^GSPC)+61.62%
5-Year Return
OGI-91.16%
S&P 500 (^GSPC)+51.64%

Growth & profitability

Annual revenue & EPS trend
Revenue FY25
$186M+16.4% YoY
Net income FY25
-$18M+60.9% YoY
Free cash flow FY25
-$25M-1580.8% YoY
Operating margin FY25
-34.1%-12.3 pts YoY
ROIC (FY25)-17.8%
Avg ROIC 5Y-20.5%
ROE (TTM)21%
Piotroski Score2 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate6/12 (50%)
Revenue Beat Rate7/12 (58%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q3 2026Latest
Aug 11, 2026
$0.54+5520.0%
vs -$0.01
$74M+9.2%
vs $68M
Q2 2026
May 12, 2026
-$0.01+5.4%
vs -$0.01
$43M-15.0%
vs $51M
Q1 2026
Feb 10, 2026
$0.11+1163.0%
vs -$0.01
$46M-13.1%
vs $53M
Q4 2025
Dec 16, 2025
-$0.20-1900.0%
vs -$0.01
$57M+9.6%
vs $52M
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

4 Stories
Business Wire·Oct 15, 2026
Organigram Provides Update on Integration of Sanity Group and Unified Global Operating Model

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (the "Company" or "Organigram"), Canada's #1 cannabis company by market share1 and a growing global cannabis platform, today provided an update on the previously announced accelerated integration of Sanity Group GmbH (“Sanity Group”) and unified global operating model, which completes the integration of Sanity Group and aligns the Company as one enterprise. The Company expects these actions, which include a series of oper.

Defense World·Oct 12, 2026
Head-To-Head Comparison: Organigram Global (NASDAQ:OGI) versus Avita Medical (NASDAQ:RCEL)

Organigram Global (NASDAQ: OGI - Get Free Report) and Avita Medical (NASDAQ: RCEL - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, risk, valuation and analyst recommendations. Profitability This table compares Organigram Global and

Defense World·Oct 6, 2026
RxSight (NASDAQ:RXST) and Organigram Global (NASDAQ:OGI) Financial Survey

RxSight (NASDAQ: RXST - Get Free Report) and Organigram Global (NASDAQ: OGI - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability. Earnings and Valuation This table compares RxSight and

Seeking Alpha·Sep 30, 2026
Organigram Global Inc. (OGI:CA) Discusses Strategic Priorities, Growth Initiatives, and Insights from Production Facilities Transcript

Organigram Global Inc. (OGI:CA) Discusses Strategic Priorities, Growth Initiatives, and Insights from Production Facilities Transcript

Filtered for Organigram Global Inc.More Headlines
04

Compare before deciding

Benchmark OGI against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for Organigram Global Inc. (OGI)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
OGI logoOGIOrganigram Global Inc.Current
$0.88$123.4M1.9516.42%28.02%21.02%—
CGC logoCGCCanopy Growth Corporation
$0.65$275.66M-1.245.8%-88.67%-37.43%—
TLRY logoTLRYTilray Brands, Inc.
$2.92$389.35M-2.3711.46%-17.05%-9.54%—
ACB logoACBAurora Cannabis Inc.
$5.24$324.58M-4.12-6.61%-38.15%-20.36%—
CRON logoCRONCronos Group Inc.
$3.61$1.35B21.6026.81%22.84%5.11%—
SNDL logoSNDLSNDL Inc.
$1.42$369.63M-8.442.82%-6.38%-5.5%—

Compare OGI vs Peers

Organigram Global Inc. (OGI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs CGC

Most directly comparable listed peer for OGI.

Scale Benchmark

vs SMG

Larger-name benchmark to compare OGI against a more recognizable public peer.

Peer Set

Compare Top 5

vs CGC, TLRY, ACB, CRON

Get notified when OGI posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

OGI Frequently Asked Questions

Organigram Global Inc. (OGI) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Organigram Global Inc.'s revenue?

Organigram Global Inc. (OGI) reported $309.1M in revenue over the trailing twelve months. Revenue was $186.1M in fiscal year 2025.

How fast is Organigram Global Inc. growing?

Organigram Global Inc. (OGI) grew revenue by 38.1% over the trailing twelve months, compared with the twelve months before.

Is OGI profitable?

Yes. Organigram Global Inc. (OGI) earned $86.6M in net income over the trailing twelve months (a 28.0% net margin).

Dividend & Returns
What is OGI's return on equity?

Organigram Global Inc. (OGI) had a return on equity (ROE) of 21.0% over the trailing twelve months. That is well above the market's typical 10-15%.

What is Organigram Global Inc.'s free cash flow?

Organigram Global Inc. (OGI) had negative free cash flow of $29.7M over the trailing twelve months.

What if you invested $1,000 in OGI back in 2012?

Total return calculator · dividends reinvested · 14+ years of data

See returns →